Novartis CEO: AI Could Cut Drug Development Time by Years
Novartis CEO Vasant Narasimhan stated that integrating artificial intelligence into the pharmaceutical research process could reduce drug development timelines from 12 years to eight. This shift aims to improve success rates for bringing new medications to market by streamlining complex testing and analysis phases.
Covered by 1 source
- BBloomberg Technology↗1d ago